Poster Abstract Session:
197. Influenza Vaccines
Saturday, October 20, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: I. Adult and Pediatric Vaccines and P. Pediatric and Perinatal Infections

Tracks: Adult ID, Pediatric ID


Pregnancy Modifies the Antibody Response to Trivalent Influenza Immunization
Elizabeth P. Schlaudecker, M.D., M.P.H. ; Monica McNeal, MS ; Caitlin Dodd, M.S. ; Joseph Ranz, B.S. ; Mark C. Steinhoff, M.D.

Influenza in Infants Born to Women Reporting Influenza Immunization During Pregnancy
Julie Shakib, DO, MPH, MSCI ; Kent Korgenski, MS ; Andrew Pavia, MD, FIDSA, FSHEA ; Carrie L. Byington, MD

Safety Assessment of MF-59 Adjuvanted Influenza Vaccine During Pregnancy
Daniel Stecher, Physician ; Emanuel Godoy, Resident ; Victoria Iannantuonno, Resident ; Vanesa Fridman, Physician ; Andrea Padovani, Physician ; Hilda Ruda Vega, Physician ; María Beatriz Lasala, Physician

Breast Milk Antibody and Neutralization Activity at One Year Postpartum after Antenatal Influenza Immunization
Mark Steinhoff, MD, FIDSA ; Elizabeth P. Schlaudecker, M.D., M.P.H. ; Saad B. Omer, MBBS, MPH, PhD ; Monica McNeal, MS ; Eliza Roy, DCH ; Shams E. Arifeen, MBBS, DrPH ; Caitlin Dodd, M.S. ; Rubhana Raqib, PhD ; Robert Breiman, MD ; Khalequ Zaman, MBBS, PhD

B-cell Response to Trivalent Inactivated versus Live-Attenuated Influenza Vaccines in Identical Twin Children
Kareem Shehab, MD ; Sanae Sasaki, PhD ; Cornelia L. Dekker, MD ; Xiao-Song He, PhD ; Harry Greenberg, MD

Immunogenicity and Safety Profile of an AS03-Adjuvanted H5N1 Vaccine in Children 6 Months to <18 Years of Age: a Randomized Multi-center Trial
Pope Kosalaraksa, MD. ; Robert Jeanfreau, MD ; Louise Frenette, MD ; Mamadou Dramé, MSc ; Miguel Madariaga, MD, MSc ; Olivier Godeaux, MD ; Patricia Izurieta, MD, Ph.D ; David Vaughn, MD, MPH

The Safety and Immunogenicity of High Dose Trivalent Influenza Vaccine (TIV) Compared to Standard Dose TIV in Pediatric Solid Organ Transplant (SOT) Patients
Sarah Rich, MD ; Marian Michaels, MD, MPH ; Jonathan A. McCullers, MD ; Wenli Wang, MS ; Steve Ampah, MS ; Alice O'Shea, RN ; Michael Green, MD, MPH ; Natasha Halasa, MD MPH

Trivalent Inactivated Influenza Vaccine (TIV) and Live Attenuated Influenza Vaccine (LAIV) Induce Different B cell Responses in Blood of Immunized Children
Raquel Giacomelli Cao, MD ; Santiago M.C. López, MD ; Emilio Flaño, PhD ; Gerlinde Obermoser, MD ; Sara Mertz, BS ; Shelli Farley ; Paulla Davies ; Adolfo Garcia-Sastre, PhD ; Randy Albrecht, PhD ; Asuncion Mejias, MD, PhD ; Octavio Ramilo, MD
  • RIS-RC-625_IDSA_RC_final.pdf (1.2 MB)

  • The Safety and Immunogenicity of High Dose Trivalent Influenza Vaccine (TIV) Compared to Standard Dose TIV in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients
    Meghann McManus, D.O. ; Haydar Frangoul, M.D. ; Jonathan A. McCullers, MD ; Wenli Wang, MS ; Steve Ampah, MS ; Alice O'Shea, RN ; Natasha Halasa, MD MPH

    Immunogenicity and Safety of FluzoneHD, a High-Dose Influenza Vaccine, versus Fluzone, a Standard-Dose Influenza Vaccine in Children with Cancer or HIV: a Randomized, Open-label, Clinical Trial
    Hana Hakim, MD, MS ; Kim J. Allison, BSN ; Lee-Ann Van De Velde, BBiomedSc(Hons) ; Amy Iverson, BS ; Patricia M. Flynn, MD, MS ; Jonathan A. McCullers, MD

    Possible Impact of the Yearly childhood Vaccinations with Trivalent Influenza Vaccine (TIV) on the Immune Response to Pandemic Strain H1N1
    Ahdi Amer, MD ; Howard Fischer, MD ; Basim Asmar, MD ; Muhammad Bilal, MD ; Priyanka Nanjireddy, MBBS
  • H1N1 Poster PDF.pdf (45.9 kB)

  • Influenza Vaccine Effectiveness in Households with Children
    Joshua G. Petrie, MPH ; Suzanne E. Ohmit, DrPH ; Ryan E. Malosh, MPH ; Arnold Monto, MD

    The Role of Nasal Secretory IgA in Children Vaccinated With Live Attenuated Influenza Vaccine
    Christopher Ambrose, MD ; Xionghua Wu, PhD ; Taff Jones, PhD ; Raburn Mallory, MD
  • FLU12015.3148.pdf (176.4 kB)

  • Automated Screening of Hospitalized Children for Influenza Vaccination
    Ari Pollack, MD, MA ; Matthew Kronman, MD, MSCE ; Danielle Zerr, MD, MPH

    School-Located Influenza Vaccinations Decrease Laboratory-Confirmed Influenza Rates and Improves School Attendance
    Pia Pannaraj, MD, MPH ; Alvin Nelson El Amin, MD, MPH ; Hailin Wang, MPH ; Chrysanthy Ha, MPH ; Hector Rivas ; Michael Smit, MD, MSPH ; Grace Aldrovandi, MD ; Laurene Mascola, MD, MPH

    Improving Influenza Immunization Rates in Children with Diabetes
    Angela Myers, MD, MPH ; David Williams, MPH ; Joseph Cernich, MD ; Arthur Williams, PhD, MA(Econ), MPA ; Mary Anne Jackson, MD, FIDSA

    Immunogenicity and Safety Profile of an AS03-adjuvanted H5N1 Influenza Vaccine Prepared from 4-year-old Stockpiled Bulk Antigen
    Patricia Izurieta, MD, Ph.D ; Mamadou Dramé, MSc ; Miguel Madariaga, MD, MSc ; Olivier Godeaux, MD ; David Vaughn, MD, MPH

    Evaluation of the Neuraminidase-Inhibiting Antibody Response to Inactivated Influenza Vaccine by Enzyme-Linked Lectin Assay
    Maryrose Laguio, MD ; Mark Thompson, Ph. D ; Manjusha Gaglani, MBBS ; Allison Naleway, PhD ; Sarah Spencer, Ph.D ; Sarah Ball, MPH, ScD ; Steven Baker, B.S., M.S. ; Luis Martinez-Sobrido, Ph.D. ; David Shay, MD, MPH ; John J. Treanor, MD

    Seasonal and Pandemic Vaccine Effectiveness in the Prevention of Influenza-related Hospitalization in Canadian Adults
    Shelly McNeil, MD ; Allison McGeer, MD, FSHEA ; Karen Green, MSc ; Ardith Ambrose, RN ; Jennie Johnstone, MD ; Todd Hatchette, MD ; Jason LeBlanc, PhD ; Duncan Webster, MD ; Mark Loeb, MD ; Anne McCarthy, MD, MSc ; Guy Boivin, MD ; Sylvie Trottier, MD ; Christina Wang ; Melissa Andrew, MD, PhD ; Louis Valiquette, MD ; Grant Stiver, MD

    Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate versus Two Trivalent Influenza Vaccines: a Randomized Controlled Trial in Adults
    Juan Carlos Tinoco, MD ; Noris Pavia-Ruz, MD, MSc ; Aurelio Cruz-Valdez, PhD ; Carlos Aranza Doniz, MD ; Vijayalakshmi Chandrasekaran, MSc ; Walthère Dewé, MSc ; Aixue Liu, MD, PhD ; Bruce L. Innis, MD ; Varsha K. Jain, MD, MPH

    Safety and Immunogenicity Comparison of 2011-2012 High-Dose and Standard Intramuscular Influenza Vaccines in Older Adults
    Corwin A. Robertson, MD, MPH ; David P. Greenberg, MD, FIDSA ; Michael D. Decker, MD, MPH
  • Abstract_1527.pdf (708.2 kB)

  • Evaluation of a Standardized Measure for Reporting Healthcare Personnel Influenza Vaccination Data, 2010-2011
    Megan C. Lindley, MPH ; Faruque Ahmed, PhD ; Suchita Lorick, DO ; Tara MacCannell, PhD ; Anita Geevarughese, MD, MPH ; Robert Harrison, MD, MPH ; David Nace, MD, MPH ; Carmela Smith, MS

    Healthcare Workers’ (HCWs) Reasons For and Against Recommending Influenza Vaccination during the 2010-2011 Influenza Season – Maricopa County, Arizona
    Bianca Salas, BIS ; Vjollca Berisha, MD, MPH ; Andrean Bunko Patterson, MPH ; Tammy Sylvester, RN, BSN ; Jennifer Stewart, MS

    CME Credits:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.